Show simple item record

dc.contributor.authorSingh, Rohitpal
dc.contributor.authorLewis, Brittany
dc.contributor.authorChapman, Brittany P
dc.contributor.authorCarreiro, Stephanie
dc.contributor.authorVenkatasubramanian, Krishna
dc.date2022-08-11T08:11:02.000
dc.date.accessioned2022-08-23T17:29:40Z
dc.date.available2022-08-23T17:29:40Z
dc.date.issued2019-02-01
dc.date.submitted2019-06-12
dc.identifier.citation<p>Biomed Eng Syst Technol Int Jt Conf BIOSTEC Revis Sel Pap. 2019 Feb;5:310-318. doi: 10.5220/0007382503100318. <a href="https://doi.org/10.5220/0007382503100318">Link to article on publisher's site</a></p>
dc.identifier.doi10.5220/0007382503100318
dc.identifier.pmid30993266
dc.identifier.urihttp://hdl.handle.net/20.500.14038/50370
dc.description.abstractWearable biosensors can be used to monitor opioid use, a problem of dire societal consequence given the current opioid epidemic in the US. Such surveillance can prompt interventions that promote behavioral change. The effectiveness of biosensor-based monitoring is threatened by the potential of a patient's collaborative non-adherence (CNA) to the monitoring. We define CNA as the process of giving one's biosensor to someone else when surveillance is ongoing. The principal aim of this paper is to leverage accelerometer and blood volume pulse (BVP) measurements from a wearable biosensor and use machine-learning for the novel problem of CNA detection in opioid surveillance. We use accelerometer and BVP data collected from 11 patients who were brought to a hospital Emergency Department while undergoing naloxone treatment following an opioid overdose. We then used the data collected to build a personalized classifier for individual patients that capture the uniqueness of their blood volume pulse and triaxial accelerometer readings. In order to evaluate our detection approach, we simulate the presence (and absence) of CNA by replacing (or not replacing) snippets of the biosensor readings of one patient with another. Overall, we achieved an average detection accuracy of 90.96% when the collaborator was one of the other 10 patients in our dataset, and 86.78% when the collaborator was from a set of 14 users whose data had never been seen by our classifiers before.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=30993266&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461698/
dc.subjectAdherence
dc.subjectBiosensor
dc.subjectMachine Learning
dc.subjectOpioid Epidemic
dc.subjectWearable Technology
dc.subjectUMCCTS funding
dc.subjectArtificial Intelligence and Robotics
dc.subjectBiomedical
dc.subjectBiomedical Devices and Instrumentation
dc.subjectBiomedical Engineering and Bioengineering
dc.subjectBiotechnology
dc.subjectMedical Toxicology
dc.subjectSubstance Abuse and Addiction
dc.subjectTranslational Medical Research
dc.titleA Machine Learning-based Approach for Collaborative Non-Adherence Detection during Opioid Abuse Surveillance using a Wearable Biosensor
dc.typeConference Paper
dc.source.volume5
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/umccts_pubs/199
dc.identifier.contextkey14724584
atmire.contributor.authoremailstephanie.carreiro@umassmed.edu
html.description.abstract<p>Wearable biosensors can be used to monitor opioid use, a problem of dire societal consequence given the current opioid epidemic in the US. Such surveillance can prompt interventions that promote behavioral change. The effectiveness of biosensor-based monitoring is threatened by the potential of a patient's collaborative non-adherence (CNA) to the monitoring. We define CNA as the process of giving one's biosensor to someone else when surveillance is ongoing. The principal aim of this paper is to leverage accelerometer and blood volume pulse (BVP) measurements from a wearable biosensor and use machine-learning for the novel problem of CNA detection in opioid surveillance. We use accelerometer and BVP data collected from 11 patients who were brought to a hospital Emergency Department while undergoing naloxone treatment following an opioid overdose. We then used the data collected to build a personalized classifier for individual patients that capture the uniqueness of their blood volume pulse and triaxial accelerometer readings. In order to evaluate our detection approach, we simulate the presence (and absence) of CNA by replacing (or not replacing) snippets of the biosensor readings of one patient with another. Overall, we achieved an average detection accuracy of 90.96% when the collaborator was one of the other 10 patients in our dataset, and 86.78% when the collaborator was from a set of 14 users whose data had never been seen by our classifiers before.</p>
dc.identifier.submissionpathumccts_pubs/199
dc.contributor.departmentDepartment of Emergency Medicine
dc.source.pages310-318


This item appears in the following Collection(s)

Show simple item record